A novel drug molecule could potentially lead to new treatments to prevent Parkinson’s disease in younger patients, according to new research.
Pluri launches manufacturing division as cell therapy pipeline progresses – Pharmaceutical Technology
Share this article In an exclusive interview with Pharmaceutical Technology, Pluri’s CEO Yaki Yanay discussed the company’s recent contract manufacturing expansion. Credit: MagioreStock via Shutterstock.